Stifel analysts maintained a Hold rating on ALX Oncology (NASDAQ:ALXO), currently trading at $1.50 with a market cap of $79.1 ...
H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...
A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast ...
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...
Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.
Predictive Oncology Inc (POAI) stock saw a modest uptick, ending the day at $1.48 which represents a slight increase of $0.21 or 16.54% from the prior close of $1.27. The stock opened at $1.58 and ...
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is ...
MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback